Clinical Trial Update: A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in China

View source ↗

Summary

A post-marketing observational study assessed the real-world effectiveness of adalimumab in Chinese patients with moderately to severely active rheumatoid arthr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Arthritis, Rheumatoid | Status: TERMINATED | Results posted: 2014-01-30